Abstract
Cardiac resistance against acute ischemia/reperfusion (I/R) injury can be enhanced by adaptation to chronic intermittent hypoxia (CIH), but the changes at the molecular level associated with this adaptation are still not fully explored. Phospholipase A2 (PLA2) plays an important role in phospholipid metabolism and may contribute to membrane destruction under conditions of energy deprivation during I/R. The aim of this study was to determine the effect of CIH (7000 m, 8 h/day, 5 weeks) on the expression of cytosolic PLA2α (cPLA2α) and its phosphorylated form (p-cPLA2α), as well as other related signaling proteins in the left ventricular myocardium of adult male Wistar rats. Adaptation to CIH increased the total content of cPLA2α by 14 % in myocardial homogenate, and enhanced the association of p-cPLA2α with the nuclear membrane by 85 %. The total number of β-adrenoceptors (β-ARs) did not change but the β2/β1 ratio markedly increased due to the elevation of β2-ARs and drop in β1-ARs. In parallel, the amount of adenylyl cyclase decreased by 49 % and Giα proteins increased by about 50 %. Besides that, cyclooxygenase 2 (COX-2) and prostaglandin E2 (PGE2) increased by 36 and 84 %, respectively. In parallel, we detected increased phosphorylation of protein kinase Cα, ERK1/2 and p38 (by 12, 48 and 19 %, respectively). These data suggest that adaptive changes induced in the myocardium by CIH may include activation of cPLA2α and COX-2 via β2-AR/Gi-mediated stimulation of the ERK/p38 pathway.
Similar content being viewed by others
References
Asemu G, Papousek F, Ostadal B, Kolar F (1999) Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial KATP channel. J Mol Cell Cardiol 31:1821–1831. doi:10.1006/jmcc.1999.1013
Neckar J, Szarszoi O, Koten L, Papousek F, Ostadal B, Grover GJ, Kolar F (2002) Effects of mitochondrial KATP modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res 55:567–575. doi:10.1016/s0008-6363(02)00456-x
Kolar F, Jezkova J, Balkova P, Breh J, Neckar J, Novak F, Novakova O, Tomasova H, Srbova M, Ostadal B, Wilhelm J, Herget J (2007) Role of oxidative stress in PKC-δ upregulation and cardioprotection induced by chronic hypoxia. Am J Physiol Heart Circ Physiol 292:H224–H230. doi:10.1152/ajpheart.00689.2006
Hlavackova M, Kozichova K, Neckar J, Kolar F, Musters RJP, Novak F, Novakova O (2010) Up-regulation and redistributon of protein kinase C-δ in chronically hypoxic heart. Mol Cell Biochem 345:271–282. doi:10.1007/s11010-010-0581-8
Ravingerova T, Matejikova J, Neckar J, Andelova E, Kolar F (2007) Differential role of PI3K/Akt pathway in the infarct size limitation and antiarrhythmic protection in the rat heart. Mol Cell Biochem 297:111–120. doi:10.1007/s11010-006-9335-z
Novotny J, Bourova L, Malkova O, Svoboda P, Kolar F (1999) G proteins, β-adrenoreceptors and β-adrenergic responsiveness in immature and adult rat ventricular myocardium: influence of neonatal hypo- and hyperthyroidism. J Mol Cell Cardiol 31:761–772. doi:10.1006/jmcc.1998.0913
Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM (2000) β2-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi. Circ Res 87:705–709. doi:10.1161/01.res.87.8.705
Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta E, Crow MT (2000) The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes thorough Gi-dependent coupling to phosphatidyl 3′-kinase. Circ Res 87:1172–1179. doi:10.1161/01.res.87.12.1172
Strniskova M, Ravingerova T, Neckar J, Kolar F, Pastorekova S, Barancik M (2006) Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen Physiol Biophys 25:25–41
Pavoine C, Behforouz N, Gauthier C, Le Gouvello S, Roudot-Thoraval F, Martin CR, Pawlak A, Feral C, Defer N, Houel R, Magne S, Amadou A, Loisance D, Duvaldestin P, Pecker F (2003) β2-adrenergic signaling in human heart: shift from the cyclic AMP to the arachidonic acid pathway. Mol Pharmacol 64:1117–1125. doi:10.1124/mol.64.5.1117
Kozlovski VI, Lomnicka M, Bartus M, Sternak M, Chlopicki S (2015) Anti-thrombotic effects of nebivolol and carvedilol: involvement of β2 receptors and COX-2/PGI2 pathways. Pharmacol Rep 67:1041–1047. doi:10.1016/j.pharep.2015.03.008
Burke JE, Dennis EA (2009) Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res 50:S237–S242. doi:10.1194/jlr.r800033-jlr200
Van Bilsen M, Van der Vusse GJ (1995) Phospholipase A2-dependent signalling in the heart. Cardiovasc Res 30:518–529. doi:10.1016/s0008-6363(95)00098-4
Cummings BS, McHowat J, Schnellmann RG (2000) Phospholipase A2s in cell injury and death. J Pharmacol Exp Ther 294:793–799
Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051. doi:10.1016/0092-8674(91)90556-e
Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269–278. doi:10.1016/0092-8674(93)90666-e
Muthalif MM, Benter IF, Uddin MR, Malik KU (1996) Calcium/calmodulin-dependent protein kinase IIα mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 271:30149–30157. doi:10.1074/jbc.271.47.30149
Anfuso CD, Lupo G, Romeo L, Giurdanella G, Motta C, Pascale A, Tirolo C, Marchetti B, Alberghina M (2007) Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCα and the MAPK/ERK cascade. J Lipid Res 48:782–793. doi:10.1194/jlr.m600489-jlr200
Kramer RM, Roberts EF, Um SL, Börsch-Haubold AG, Watson SP, Fisher MJ, Jakubowski JA (1996) p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in trombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 271:27723–27729. doi:10.1074/jbc.271.44.27723
Hammarberg C, Fredholm BB, Schulte G (2004) Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3′-kinase. Biochem Pharmacol 67(1):129–134. doi:10.1016/j.bcp.2003.08.031
Graves LM, Lawrence JC Jr (1996) Insulin, growth factors, and cAMP: antagonism in the signal transduction pathways. Trends Endocrinol Metab 7(2):43–50. doi:10.1016/1043-2760(95)00204-9
Novotny J, Bourova L, Kolar F, Svoboda P (2001) Membrane-Bound and cytosolic forms of heterotrimeric G proteins in young and adult rat myocardium: influence of neonatal hypo- and hyperthyroidism. J Cell Biochem 82:215–224. doi:10.1002/jcb.1157
Jirkovsky E, Popelova O, Krivakova-Stankova P, Vavrova A, Hroch M, Haskova P, Brcakova-Dolezelova E, Mucida S, Adamcova M, Simunek T, Cervinkova Z, Gersl V, Sterba M (2012) Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways. J Pharmacol Exp Ther 343:468–478. doi:10.1124/jpet.112.198358
Klevstig M, Manakov D, Kasparova D, Brabcova I, Papousek F, Zurmanova J, Zidek V, Silhavy J, Neckar J, Pravenec M, Kolar F, Novakova O, Novotny J (2013) Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats. Pflugers Arch 465:1477–1486. doi:10.1007/s00424-013-1281-5
Waskova-Arnostova P, Elsnicova B, Kasparova D, Hornikova D, Kolar F, Novotny J, Zurmanova J (2015) Cardioprotective adaptation of rats to intermittent hypobaric hypoxia is accompanied by the increased association of hexokinase with mitochondria. J Appl Physiol 119:1487–1493. doi:10.1152/japplphysiol.01035.2014
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartensen V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682. doi:10.1038/nmeth.2019
Manders EMM, Verbeek FJ, Aten JA (1993) Measurement of co-localization of objects in dual-colour confocal images. J Microsc 169:375–382. doi:10.1111/j.1365-2818.1993.tb03313.x
Holzerova K, Hlavackova M, Zurmanova J, Borchert G, Neckar J, Kolar F, Novak F, Novakova O (2015) Involvement of PKCε in cardioprotection induced by adaptation to chronic continuous hypoxia. Physiol Res 64:191–201
Hofgaard JP, Sigurdardottir KS, Treiman M (2006) Protection by 6-aminonicotinamide against oxidative stress in cardiac cells. Pharmacol Res 54:303–310. doi:10.1016/j.phrs.2006.06.007
Winstead MV, Lucas KK, Dennis EA (2005) Group IV cytosolic phospholipase A2 mediates arachidonic acid release in H9c2 rat cardiomyocytes cells in response to hydrogen peroxide. Prostaglandins Other Lipid Mediat 78:55–66. doi:10.1016/j.prostaglandins.2005.03.004
Grewal S, Herbert SP, Ponnambalam S, Walker JH (2005) Cytosolic phospholipase A2α and cyclooxygenase 2 localize to itracellular membranes of EA.hy.926 endothelial cell that are distinct from the endoplasmic reticulum and the Golgi apparatus. FEBS J 272:1278–1290. doi:10.1111/j.1742-4658.2005.04565.x
Spencer AG, Woods JW, Arakawa T, Singer II, Smith WL (1998) Subcellular localization of prostaglandin endoperoxide H synthase-1 and -2 by immunoelectron microscopy. J Biol Chem 273:9886–9893. doi:10.1074/jbc.273.16.9886
Morel S, Milano G, Ludunge KM, Corno AF, Samaja M, Fleury S, Bonny Ch, Kappenberger L, Segesser LK, Vassalli G (2006) Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function. Basic Res Cardiol 101:336–345. doi:10.1007/s00395-006-0596-1
Rafiee P, Shi Y, Kong X, Kirkwood A, Pritchard KA, Tweddell JS, Litwin SB, Mussatto K, Jaquiss RD, Su J, Baker JE (2002) Activation of protein kinases in chronically hypoxic infant human and rabbit hearts. Circulation 106:239–245. doi:10.1161/01.cir.0000022018.68965.6d
Seko Y, Takahashi N, Tobe K, Kadowaki T, Yazaki Y (1997) Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinases (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 239:840–844. doi:10.1006/bbrc.1997.7570
Clerk A, Fuller SJ, Michael A, Sugden PH (1998) Stimulation of stress-regulated mitogen-activated protein kinases (stress-activated protein kinases/c-Jun-N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273:7228–7234. doi:10.1074/jbc.273.13.7228
You HJ, Lee JW, Yoo YJ, Kim JH (2004) A pathway involving protein kinase Cδ up-regulates cytosolic phospholipase A2α in airway epithelium. Biochem Biophys Res Commun 321:657–664. doi:10.1016/j.bbrc.2004.07.022
Svoboda P, Teisinger J, Novotny J, Bourova L, Drmota T, Hejnova L, Moravcova Z, Lisy V, Rudajev V, Stohr J, Vokurkova A, Svandova I, Durchánkova D (2004) Biochemistry of transmembrane signaling mediated by trimeric G proteins. Physiol Res 53:S141–S152
Chakraborti T, Das S, Chakraborti S (2005) Proteolytic activation of protein kinase Cα by peroxynitrite in stimulating cytosolic phospholipase A2 in pulmonary endothelium: involvement of a Pertussis toxin sensitive protein. Biochemistry 44:5246–5257. doi:10.1021/bi0477889
León-Velarde F, Bourin MC, Germack R, Mohammadi K, Crozatier B, Richalet JP (2001) Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion. Am J Physiol Regul Integr Comp Physiol 280:R274–R281
Hrbasova M, Novotny J, Hejnova L, Kolar F, Neckar J, Svoboda P (2003) Altered myocardial Gs protein and adenylyl cyclase signaling in rats exposed to chronic hypoxia and normoxic recovery. J Appl Physiol 94:2423–2432. doi:10.1152/japplphysiol.00958.2002
Hahnova K, Kasparova D, Zurmanova J, Neckar J, Kolar F, Novotny J (2016) β-adrenergic signaling in rat heart is similarly affected by continuous and intermittent normobaric hypoxia. Gen Physiol Biophys 35:165–173. doi:10.4149/gpb_2015053
Kacimi R, Moalic JM, Aldashev A, Vatner DE, Richalet JP, Crozatier B (1995) Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia. Am J Physiol 269:H1865–H1873
Pei JM, Yu XC, Fung ML, Zhou JJ, Cheung CS, Wong NS, Leung MP, Wong TM (2000) Impaired Gsα and adenylyl cyclase cause β-adrenoceptor desensitization in chronically hypoxic rat hearts. Am J Physiol Cell Physiol 279:C1455–C1463
Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF, Ishikawa Y (2003) Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci USA 100:9986–9990. doi:10.1073/pnas.1733772100
Tong H, Bernstein D, Murphy E, Steenbergen Ch (2005) The role of β-adrenergic receptor signaling in cardioprotection. FASEB J 19:983–985. doi:10.1096/fj.04-3067fje
Daaka Y, Luttrell LM, Lefkowitz RJ (1997) Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88–91. doi:10.1038/36362
Magne S, Couchie D, Pecker F, Pavoine C (2001) β2-adrenergic receptor agonists increase intracellular free Ca2+ concentration cycling in ventricular cardiomyocytes through p38 and p42/44 MAPK-mediated cytosolic phospholipase A2 activation. J Biol Chem 276:39539–39548. doi:10.1074/jbc.m100954200
Mackay K, Mochly-Rosen D (2001) Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc Res 50:65–74. doi:10.1016/s0008-6363(00)00322-9
Air-Mamar B, Cailleret M, Rucker-Martin C, Bouabdallah A, Candiani G, Adamy C, Duvaldestin P, Pecker F, Defer N, Pavoine C (2005) The cytosolic phospholipase A2 pathway, a safeguard of β2-adrenergic cardiac effects in rat. J Biol Chem 280:18881–18890. doi:10.1074/jbc.m410305200
Dang H, Elliott JJ, Lin AL, Zhu B, Katz MS, Yeh CK (2008) Mitogen-activated protein kinase up-regulation and activation during rat parotid gland atrophy and regeneration: role of epidermal growth factor and β2-adrenergic receptors. Differentiation 76:546–557. doi:10.1111/j.1432-0436.2007.00251.x
Sato S, Shirato K, Mitsuhashi R, Inoue D, Kizaki T, Ohno H, Tachiyashiki K, Imaizumi K (2013) Intracellular β2-adrenergic receptor signaling specificity in mouse skeletal muscle in response to single-dose β2-agonist clenbuterol treatment and acute exercise. J Physiol Sci 63:211–218. doi:10.1007/s12576-013-0253-z
Saluja I, Song D, O’Regan MH, Phillis JW (1997) Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett 233:97–100. doi:10.1016/s0304-3940(97)00646-0
Kerkelä R, Boucher M, Zaka R, Gao E, Harris D, Piuhola J, Song J, Serpi R, Woulfe KC, Cheung JY, O’Leary E, Bonventre JV, Force T (2011) Cytosolic phospholipase A2α protects against ischemia/reperfusion injury in the heart. Clin Transl Sci 4:236–242. doi:10.1111/j.1752-8062.2011.00294.x
Engelbrecht AM, Ellis B (2007) Apoptosis is mediated by cytosolic phospholipase A2 during simulated ischaemia/reperfusion-induced injury in neonatal cardiac myocytes. Prostaglandins Leukot Essent Fatty Acids 77:37–43. doi:10.1016/j.plefa.2007.06.002
Félétou M, Huang Y, Vanhoutte PM (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164:894–912. doi:10.1111/j.1476-5381.2011.01276.x
Chytilova A, Borchert GH, Mandikova-Alanova P, Hlavackova M, Kopkan L, Khan MA, Imig JD, Kolar F, Neckar J (2015) Tumour necrosis factor-α contributes to improved cardiac ischaemic tolerance in rats adapted to chronic continuous hypoxia. Acta Physiol (Oxf) 214:97–108. doi:10.1111/apha.12489
Schmedtje JF Jr, Ji YS, Liu WL, Dubois RN, Runge MS (1997) Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601–608. doi:10.1074/jbc.272.1.601
Oshima K, Takeyoshi I, Tsutsumi H, Mohara J, Ohki S, Koike N, Nameki T, Matsumoto K, Morishita Y (2006) Inhibition of cyclooxygenase-2 improves cardiac function following long-term preservation. J Surg Res 135:380–384. doi:10.1016/j.jss.2006.03.044
Bolli R, Shinmura K, Tang XL, Kodani E, XuanYT Guo Y, Dawn B (2002) Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 55:506–519. doi:10.1016/s0008-6363(02)00414-5
Acknowledgments
This work was supported by the Charles University Grant Agency (392615), the Czech Science Foundation (13-10267S), the Ministry of Education, Youth and Sport of the Czech Republic (SVV-260313/2016) and the Operational Program OP VaVpI (CZ.1.05/4.1.00/16.0347).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
There is no conflict of interest.
Rights and permissions
About this article
Cite this article
Micova, P., Hahnova, K., Hlavackova, M. et al. Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation. Mol Cell Biochem 423, 151–163 (2016). https://doi.org/10.1007/s11010-016-2833-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-016-2833-8